Registering a pharmaceutical product in the UAE now runs through the Emirates Drug Establishment (EDE), the federal authority under the pharmaceutical law in force from 2025. This guide sets out the sequence we run for foreign manufacturers: site registration, classification, dossier, submission, and certificate, plus the points where files most often lose time.
Who regulates pharmaceutical registration in 2026
Under the UAE pharmaceutical law in force from 2025, the EDE is the federal authority for pharmaceutical facility licensing, product classification, product registration and marketing authorisation, manufacturing site registration, import and export permits, and GMP, GDP, and GSP oversight. These functions transferred from the Ministry of Health and Prevention (MOHAP).
MOHAP has not left the stage. It retains community and compounding pharmacy licensing and certain narcotics controls. In Dubai, the DHA licenses health facilities and telehealth, and Dubai Municipality registers consumer products. For a manufacturer registering a medicine, however, the EDE is the counterpart, and the rest of this guide assumes that route.
What a first-time foreign manufacturer needs
A first-time foreign manufacturer needs three things, in a fixed order: registration of the manufacturing site (a one-off step per site), product classification where the category is unclear, and then product registration for each product. You also need a UAE licensed local representative to hold the marketing authorisation and manage the file. We act as Local Representative and Marketing Authorisation Holder (MAH) through our own licensed pharmaceutical facility, and our pharmaceutical product registration service runs the full sequence.
Before you file
- Site registration and product registration certificates are each valid 5 years
- Dossiers, labels, and leaflets must be available in English and Arabic
- Generic products include bioequivalence studies against the innovator in the CTD dossier; no local UAE studies are required
- EDE inspections of foreign manufacturing sites are discretionary, not guaranteed
- Only licensed UAE facilities and medical warehouses holding an EDE import permit may import pharmaceuticals
The registration sequence, step by step
The sequence below is the path we run for a standard file. Some steps can overlap, but the order of dependencies does not change.
Appoint a local representative
Foreign manufacturers register through a UAE licensed entity that acts as MAH and submits on their behalf. You keep ownership of the registration and can move it to another representative later.
Register the manufacturing site
A one-off registration per site, valid 5 years. Inspections of foreign sites are at the EDE's discretion rather than guaranteed, and an appeal can request an inspection visit.
Confirm the classification
Where the category is unclear, classification is the first step. The decision fixes the pathway, the dossier expectations, and the timeline, so we settle it before compiling anything.
Compile the CTD dossier
Quality, safety, and efficacy data in CTD format, with documents available in English and Arabic. For generics, bioequivalence studies against the innovator product are included in the dossier.
Submit and answer queries
The local representative submits the application and manages authority questions. Response speed on queries is one of the few timeline levers you control.
Certificate and importation
The registration certificate is valid 5 years. Importation then moves under EDE import permits through a licensed importer, a role we cover under our own warehouse and importer licences.
Timelines and validity
Pharmaceutical registration timelines vary by pathway, which is why we scope each product before committing to a schedule. For medical devices and classified products, registration takes approximately 4 to 6 weeks from complete submission, subject to authority response times. The phrase that matters is complete submission: most delay is created before filing, not after it.
Both certificates run on a 5 year cycle. Renewals are predictable, so we diarise them at grant rather than treating them as a future problem.
Where files lose time
- Compiling the dossier before the manufacturing site is registered, so the file waits on its own prerequisite
- Assuming a product category instead of confirming classification with the EDE
- Artwork and leaflets prepared in English only, when English and Arabic are required
- Generic files submitted without the bioequivalence study against the innovator
- No importation plan, when only licensed facilities and medical warehouses holding an EDE import permit may import
Frequently asked questions
How long does pharmaceutical registration take in the UAE?
Do we need our own UAE company to register a product?
Are local bioequivalence studies required for generics?
How long is a UAE registration certificate valid?
Explore our pharmaceutical product registration service
This guide is general information, not regulatory or legal advice. Requirements evolve and individual products raise specific questions, so confirm current rules with the relevant authority or contact our team before acting on it.